ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
2019年08月02日 09時00分
Source:
Eisai
エーザイ、人事異動ならびに組織改編(2019年8月1日付)を発表
東京, 2019年08月02日 - (JCN Newswire) - エーザイ株式会社は、このたび、人事異動ならびに組織改編(2019年8月1日付)を発表しました。
2019年8月1日付 人事異動
■ オンコロジービジネスグループ
新任務/旧任務/氏名
レンビマ コ・グローバルリード(兼)エーザイ・ジャパン マーケティング推進本部 レンビマ特命担当 部長(兼)レンビマHCCブランドリード/エーザイ・ジャパン マーケティング推進本部 レンビマ特命担当 部長(兼)レンビマHCCブランドリード/春名 克哉
2019年8月1日付 主な組織改編
■ オンコロジービジネスグループ
1. レンビマ コ・グローバルリードの任命
レンビマのブランド戦略のさらなる強化を企図して、グローバルマーケティングポリシーならびに戦略の立案と実行などの任務にあたるレンビマ コ・グローバルリードを任命する。
本リリースの詳細は下記をご参照ください。
https://www.eisai.co.jp/news/2019/news201961.html
概要:エーザイ株式会社
詳細はwww.eisai.co.jpをご覧ください。
Source: Eisai
セクター: バイオテック
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Mitsubishi Motors Begins Shipping Xforce HEV Model in Thailand
Apr 11, 2025 15:03 JST
Collaboration to Make Engine-Equipped Vehicles Carbon Neutral Using Synthetic Fuel
Apr 11, 2025 14:03 JST
TGR to Launch Evolved GR Yaris
Apr 11, 2025 13:35 JST
Fujitsu develops employee training platform for Seven-Eleven Japan to accelerate store digitalization
Apr 11, 2025 11:29 JST
Mitsubishi Corporation makes DennoKotsu an equity-method affiliate company, strengthening efforts to address regional transportation challenges
Apr 11, 2025 10:39 JST
JCB Enhances Customer Experience with Expanded Payment Acceptance for App Store and Apple Services in Asia
Apr 11, 2025 10:00 JST
Fujitsu and Headwaters trial on-device generative AI solution to streamline JAL cabin crew workflows
Apr 11, 2025 09:07 JST
Mitsubishi Logisnext Delivers Container Terminal Gate System with Enhanced Functionality to Port of Osaka
Apr 10, 2025 16:23 JST
Mitsubishi Shipbuilding Acquired Approval in Principle (AiP) from Classification Society for the Basic Design of an Onboard Carbon Capture and Storage System
Apr 10, 2025 14:17 JST
Honda NC750X Named Winner in 2025 Red Dot Design Award: Product Design Category, EM1 e: Wins 2025 iF Design Award: Product Design Category
Apr 10, 2025 13:13 JST
Mitsubishi Corporation to Participate in Demonstration Project for New Hydrogen-Based Ironmaking
Apr 09, 2025 18:22 JST
SinoMab BioScience Limited Breakthrough Phase 1b POC Results for SM17 in Atopic Dermatitis
Apr 09, 2025 15:49 JST
Intelligent Joy Limited Signs MOU with Smart IR and CLS Press to Collaborate on AI-Driven Investor Relations Platform
Apr 09, 2025 14:57 JST
MHIEC Completes Refurbishment of Core Facilities of Waste-to-Energy Plant in Miyazaki City
Apr 09, 2025 14:19 JST
NEC Face Recognition Ranks First in NIST Accuracy Testing
Apr 09, 2025 11:09 JST
Sonofai revolutionizes frozen tuna inspection with new device incorporating Fujitsu AI tech
Apr 09, 2025 10:30 JST
NEC Orchestrating Future Fund invests in Rescale, Inc., provider of a leading digital engineering platform for cloud high-performance computing (HPC)
Apr 08, 2025 16:42 JST
SITA and NEC Collaborate to Drive Global Adoption of Digital Identities in Travel
Apr 08, 2025 16:11 JST
Gome Retail Continues to Focus on Its Main Business and Actively Resolve Debt
Apr 07, 2025 22:29 JST
Xforce HEV Model Earns the Highest Rating of Five Stars in 2024 ASEAN NCAP
Apr 07, 2025 15:56 JST
More Latest Release >>
Related Release
Eisai to Divest Rights for Pariet in China to Peak Pharma
4/1/2025 1:15:00 PM JST
World's First Early Alzheimer's Disease Treatment Developed in Japan LEQEMBI Receives Prime Minister's Award at the 12th Technology Management and Innovation Awards
3/25/2025 5:28:00 PM JST
Eisai Selected as a Nadeshiko Brand 2025 as a Listed Company Excelling in Promotion of Women in the Workplace
3/25/2025 12:21:00 PM JST
Eisai Recognized as "2025 Kenko Investment for Health" for the First Time and Certified as "Outstanding Organization Of Kenko Investment for Health Program (White 500)" for the Sixth Time
3/10/2025 8:24:00 PM JST
Eisai: Update on the Co-Promotion of the Oral Antifungal Agent Nailin Capsules 100mg in Japan
3/5/2025 9:09:00 AM JST
Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer's Disease in Australia
3/4/2025 5:22:00 PM JST
"Fatigue Recovery While You Sleep!" Eisai to Launch Designated Quasi-Drug Drink "Chocola BB Nightwell"
3/3/2025 3:41:00 PM JST
The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease
3/3/2025 1:53:00 PM JST
Eisai Enters into License Agreement for the Development and Distribution of Fibroblast Growth Factor (FGF) Receptor Selective Tyrosine Kinase Inhibitor Tasurgratinib in Greater China Region (Mainland China, Hong Kong, Macau, and Taiwan) with SciClone
2/28/2025 12:31:00 PM JST
Eisai Selected for "Human Capital Leaders 2024" and "Human Capital Management Gold Quality" for Second Consecutive Year, as a Company Committed to Excellent Management and Disclosure of Human Capital Initiatives
2/20/2025 1:29:00 PM JST
More Press release >>